Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2567)
All Articles published online
|
Jul 28, 2010 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wich C, Agaimy A, Strobel D, Wissniowski TT, Hartmann A, Ocker M. Sustained treatment response of metastatic hepatocellular carcinoma with bevacizumab and sorafenib. World J Gastroenterol 2010; 16(28): 3592-3596 [PMID: 20653070 DOI: 10.3748/wjg.v16.i28.3592] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i28/3592.htm |
| Number | Citing Articles |
| 1 |
Eva Dazert, Michael N Hall. mTOR signaling in disease. Current Opinion in Cell Biology 2011; 23(6): 744 doi: 10.1016/j.ceb.2011.09.003
|
| 2 |
Omar Abdel-Rahman. Systemic therapy for hepatocellular carcinoma (HCC): from bench to bedside. Journal of the Egyptian National Cancer Institute 2013; 25(4): 165 doi: 10.1016/j.jnci.2013.08.002
|
| 3 |
|
| 4 |
Anne M. Marsh, Louise Lo, Ronald A. Cohen, James H. Feusner. Sorafenib and bevacizumab for recurrent metastatic hepatoblastoma: Stable radiographic disease with decreased AFP. Pediatric Blood & Cancer 2012; 59(5): 939 doi: 10.1002/pbc.24171
|
| 5 |
Stephanie Coulon, Femke Heindryckx, Anja Geerts, Christophe Van Steenkiste, Isabelle Colle, Hans Van Vlierberghe. Angiogenesis in chronic liver disease and its complications. Liver International 2011; 31(2): 146 doi: 10.1111/j.1478-3231.2010.02369.x
|
| 6 |
Stephanie Coulon, Sven Francque, Isabelle Colle, An Verrijken, Bram Blomme, Femke Heindryckx, Steffi De Munter, Janne Prawitt, Sandrine Caron, Bart Staels, Hans Van Vlierberghe, Luc Van Gaal, Anja Geerts. Evaluation of inflammatory and angiogenic factors in patients with non-alcoholic fatty liver disease. Cytokine 2012; 59(2): 442 doi: 10.1016/j.cyto.2012.05.001
|
| 7 |
坤 钱. Bevacizumab: Current Approach in the Treatment of Hepatocellular Carcinoma. Medical Diagnosis 2011; 1(01): 1 doi: 10.12677/md.2011.11001
|